| Compound | Adipotide (FTPP) |
|---|---|
| Category | Vasculature-targeting peptidomimetic |
| Class | Growth Hormone and Growth Factors |
| Evidence tier | Preclinical |
| WADA status | Not individually listed; verify current status if subject to testing |
| Sold on this site | No — this is a reference database |
Overview
Adipotide (FTPP) is catalogued here as a vasculature-targeting peptidomimetic and graded at the "Preclinical" evidence tier. The evidence base for this compound is dominated by animal and cell-culture studies. Mechanism may be plausible; human benefit and safety are unestablished.
An experimental peptidomimetic designed to bind prohibitin receptors on white-adipose blood vessels and trigger their regression — an approach to fat loss through vascular targeting.
Mechanism of Action
Adipotide homes to prohibitin-expressing adipose vasculature, inducing endothelial apoptosis, loss of blood supply, and resorption of fat tissue.
Research and Evidence
Primate studies reported substantial fat loss — accompanied by kidney toxicity signals that exemplify the approach’s risks. Human trials were never conducted.
Safety and Side Effects
Renal adverse effects in animal studies halted development; no human safety data.
Frequently Asked Questions
What is the evidence tier of Adipotide (FTPP)?
Adipotide (FTPP) is graded "Preclinical" on this site. The evidence base for this compound is dominated by animal and cell-culture studies. Mechanism may be plausible; human benefit and safety are unestablished.
Is Adipotide (FTPP) an approved medicine?
No. Preclinical means the compound has not reached universal regulatory approval; the tier description above explains exactly what level of evidence exists.
Where can I read the primary studies for Adipotide (FTPP)?
The references section at the end of this entry links the key primary sources — regulator labels, trial registrations, and peer-reviewed papers. Our "How to Read a Peptide Study" guide explains how to evaluate them.
References
- ClinicalTrials.gov — search for adipotide studies (none registered). [source]
Evidence tier: Preclinical · Last reviewed: 2026-09-05 · Sources cited below.